Waters Corp WAZ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €386.00
- Day Range
- €381.60–381.60
- 52-Week Range
- —–—
- Bid/Ask
- €382.80 / €386.40
- Shares Outstanding
- 98.25M
- Market Cap
- $37.49B
- Volume/Avg
- — / 13
Key Statistics
- Price/Earnings (Normalized)
- 32.91
- Price/Sales
- 7.26
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.03%
Company Profile
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Mid Core
- Total Number of Employees
- 7,900
- Website
- https://www.waters.com
Competitors
Valuation
|
Metric
|
WAZ
|
A
|
DHR
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.91 | 28.32 | 27.44 |
Price/Book Value | 2.85 | 6.57 | 2.98 |
Price/Sales | 7.26 | 6.60 | 6.31 |
Price/Cash Flow | 28.09 | 25.65 | 22.11 |
Price/Earnings
WAZ
A
DHR
Financial Strength
|
Metric
|
WAZ
|
A
|
DHR
|
|---|---|---|---|
Quick Ratio | 1.05 | 1.41 | 1.03 |
Current Ratio | 1.86 | 2.05 | 1.65 |
Interest Coverage | 2.23 | 16.08 | 16.95 |
Quick Ratio
WAZ
A
DHR
Profitability
|
Metric
|
WAZ
|
A
|
DHR
|
|---|---|---|---|
Return on Assets (Normalized) | 7.79% | 13.27% | 5.34% |
Return on Equity (Normalized) | 13.28% | 24.92% | 8.59% |
Return on Invested Capital (Normalized) | 10.35% | 16.95% | 6.45% |
Return on Assets
WAZ
A
DHR
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|Fv^LBxm# | LOCK|<$ | $245B | |||
| Danaher Corp
DHR
| LOCK|lfN#^T@ | LOCK|fGG | $157B | |||
| Agilent Technologies Inc
A
| LOCK|>hs#PBbH | LOCK|#b | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|@!vm&?z | LOCK|jfFr! | $43B | |||
| Waters Corp
WAT
| LOCK|GBML@N | LOCK|%V | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|NMr?##>$ | LOCK|zL | $41B | |||
| Illumina Inc
ILMN
| LOCK|%D$xnXl | LOCK|%!xxm | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|q&k<<Fx | LOCK|Dq&? | $32B | |||
| Quest Diagnostics Inc
DGX
| LOCK|&GYh!?! | LOCK|pb>$ | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|w#DF@ct | LOCK|B<rVb | $25B |
United States